
John P. Nguyen
Examiner (ID: 16015, Phone: (571)270-5877 , Office: P/1619 )
| Most Active Art Unit | 1619 |
| Art Unit(s) | 1619 |
| Total Applications | 491 |
| Issued Applications | 194 |
| Pending Applications | 56 |
| Abandoned Applications | 252 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 17154759
[patent_doc_number] => 20210315810
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-10-14
[patent_title] => COMPOSITION CONTAINING A MUCOLYTIC AGENT FOR THE TREATMENT OF MUCUS HYPERSECRETION AND A DEVICE FOR THE DOSING THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/265195
[patent_app_country] => US
[patent_app_date] => 2019-08-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11109
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 47
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17265195
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/265195 | COMPOSITION CONTAINING A MUCOLYTIC AGENT FOR THE TREATMENT OF MUCUS HYPERSECRETION AND A DEVICE FOR THE DOSING THEREOF | Aug 6, 2019 | Abandoned |
Array
(
[id] => 18824410
[patent_doc_number] => 11839674
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-12-12
[patent_title] => Compositions comprising silicon dioxide-based particles including one or more agents
[patent_app_type] => utility
[patent_app_number] => 16/455719
[patent_app_country] => US
[patent_app_date] => 2019-06-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 67103
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 114
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16455719
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/455719 | Compositions comprising silicon dioxide-based particles including one or more agents | Jun 26, 2019 | Issued |
Array
(
[id] => 15320775
[patent_doc_number] => 20200000717
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-01-02
[patent_title] => FILM FORMULATIONS CONTAINING DEXMEDETOMIDINE AND METHODS OF PRODUCING THEM
[patent_app_type] => utility
[patent_app_number] => 16/453679
[patent_app_country] => US
[patent_app_date] => 2019-06-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 32120
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 68
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16453679
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/453679 | Film formulations containing dexmedetomidine and methods of producing them | Jun 25, 2019 | Issued |
Array
(
[id] => 16640828
[patent_doc_number] => 10918649
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-02-16
[patent_title] => System for providing birth control
[patent_app_type] => utility
[patent_app_number] => 16/448399
[patent_app_country] => US
[patent_app_date] => 2019-06-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 23
[patent_figures_cnt] => 24
[patent_no_of_words] => 24563
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 125
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16448399
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/448399 | System for providing birth control | Jun 20, 2019 | Issued |
Array
(
[id] => 15019361
[patent_doc_number] => 20190320685
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-10-24
[patent_title] => METHOD FOR TREATMENT OR PREVENTION OF GILL DISEASE
[patent_app_type] => utility
[patent_app_number] => 16/437635
[patent_app_country] => US
[patent_app_date] => 2019-06-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5102
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 42
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16437635
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/437635 | Method for treatment or prevention of gill disease | Jun 10, 2019 | Issued |
Array
(
[id] => 16153425
[patent_doc_number] => 20200214945
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-07-09
[patent_title] => SKIN-BRIGHTENING COSMETIC MASK SYSTEM
[patent_app_type] => utility
[patent_app_number] => 16/431332
[patent_app_country] => US
[patent_app_date] => 2019-06-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14144
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 75
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16431332
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/431332 | SKIN-BRIGHTENING COSMETIC MASK SYSTEM | Jun 3, 2019 | Abandoned |
Array
(
[id] => 17241795
[patent_doc_number] => 20210361538
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-11-25
[patent_title] => PERSONAL CLEANSING SOAP BAR COMPOSITION
[patent_app_type] => utility
[patent_app_number] => 17/055150
[patent_app_country] => US
[patent_app_date] => 2019-06-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5049
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 59
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17055150
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/055150 | Personal cleansing soap bar composition | Jun 2, 2019 | Issued |
Array
(
[id] => 17227023
[patent_doc_number] => 20210353579
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-11-18
[patent_title] => HIGH PENETRATION COMPOSITIONS AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/421735
[patent_app_country] => US
[patent_app_date] => 2019-05-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 44126
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -42
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16421735
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/421735 | HIGH PENETRATION COMPOSITIONS AND USES THEREOF | May 23, 2019 | Abandoned |
Array
(
[id] => 17065037
[patent_doc_number] => 20210267252
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-09-02
[patent_title] => COMPOSITION COMPRISING HUMAN MILK OLIGOSACCHARIDES FOR USE IN IMPROVING, ENHANCING, PROMOTING OR MODULATING A SEROTONERGIC FUNCTION IN THE CENTRAL NERVOUS SYSTEM
[patent_app_type] => utility
[patent_app_number] => 17/255017
[patent_app_country] => US
[patent_app_date] => 2019-05-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10909
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17255017
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/255017 | COMPOSITION COMPRISING HUMAN MILK OLIGOSACCHARIDES FOR USE IN IMPROVING, ENHANCING, PROMOTING OR MODULATING A SEROTONERGIC FUNCTION IN THE CENTRAL NERVOUS SYSTEM | May 20, 2019 | Pending |
Array
(
[id] => 18245946
[patent_doc_number] => 11602509
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-03-14
[patent_title] => Salt of cysteamine for the preparation of highly respirable particles
[patent_app_type] => utility
[patent_app_number] => 17/050875
[patent_app_country] => US
[patent_app_date] => 2019-05-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 4973
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17050875
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/050875 | Salt of cysteamine for the preparation of highly respirable particles | May 16, 2019 | Issued |
Array
(
[id] => 16916305
[patent_doc_number] => 20210189397
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-06-24
[patent_title] => SELF-MANAGEABLE ABNORMAL SCAR TREATMENT WITH SPHERICAL NUCLEIC ACID (SNA) TECHNOLOGY
[patent_app_type] => utility
[patent_app_number] => 17/054441
[patent_app_country] => US
[patent_app_date] => 2019-05-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8493
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -31
[patent_words_short_claim] => 64
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17054441
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/054441 | SELF-MANAGEABLE ABNORMAL SCAR TREATMENT WITH SPHERICAL NUCLEIC ACID (SNA) TECHNOLOGY | May 9, 2019 | Pending |
Array
(
[id] => 17286228
[patent_doc_number] => 11202766
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2021-12-21
[patent_title] => Pharmaceutical compositions including hydrocodone bitartrate and guaifenesin
[patent_app_type] => utility
[patent_app_number] => 16/391399
[patent_app_country] => US
[patent_app_date] => 2019-04-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 14
[patent_no_of_words] => 22608
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 120
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16391399
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/391399 | Pharmaceutical compositions including hydrocodone bitartrate and guaifenesin | Apr 22, 2019 | Issued |
Array
(
[id] => 16168224
[patent_doc_number] => 10709764
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-07-14
[patent_title] => Use of compounds with thrombopoietic activity to promote bone growth and healing
[patent_app_type] => utility
[patent_app_number] => 16/392246
[patent_app_country] => US
[patent_app_date] => 2019-04-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 16
[patent_no_of_words] => 7215
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 57
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16392246
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/392246 | Use of compounds with thrombopoietic activity to promote bone growth and healing | Apr 22, 2019 | Issued |
Array
(
[id] => 18215277
[patent_doc_number] => 11590190
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-02-28
[patent_title] => Multi-nutrient supplement and uses thereof
[patent_app_type] => utility
[patent_app_number] => 16/389326
[patent_app_country] => US
[patent_app_date] => 2019-04-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7186
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 189
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16389326
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/389326 | Multi-nutrient supplement and uses thereof | Apr 18, 2019 | Issued |
Array
(
[id] => 18699974
[patent_doc_number] => 11786460
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-10-17
[patent_title] => Pharmaceutical dry powder composition for inhalation comprising a thyroid hormone
[patent_app_type] => utility
[patent_app_number] => 17/048483
[patent_app_country] => US
[patent_app_date] => 2019-04-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3759
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 110
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17048483
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/048483 | Pharmaceutical dry powder composition for inhalation comprising a thyroid hormone | Apr 9, 2019 | Issued |
Array
(
[id] => 16341758
[patent_doc_number] => 20200306408
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-10-01
[patent_title] => CYCLODEXTRIN CONTAINING FRESHENING COMPOSITION
[patent_app_type] => utility
[patent_app_number] => 16/367419
[patent_app_country] => US
[patent_app_date] => 2019-03-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7423
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 27
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16367419
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/367419 | CYCLODEXTRIN CONTAINING FRESHENING COMPOSITION | Mar 27, 2019 | Abandoned |
Array
(
[id] => 16581330
[patent_doc_number] => 20210015732
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-01-21
[patent_title] => LIQUID LIPID COMPOSITE COMPOSITION FOR IMPROVING HAIR CONDITION
[patent_app_type] => utility
[patent_app_number] => 17/041300
[patent_app_country] => US
[patent_app_date] => 2019-03-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7756
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 44
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17041300
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/041300 | Liquid lipid composite composition for improving hair condition | Mar 21, 2019 | Issued |
Array
(
[id] => 17966990
[patent_doc_number] => 11484494
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-11-01
[patent_title] => Adenovirus formulations
[patent_app_type] => utility
[patent_app_number] => 16/298071
[patent_app_country] => US
[patent_app_date] => 2019-03-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 10520
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 39
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16298071
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/298071 | Adenovirus formulations | Mar 10, 2019 | Issued |
Array
(
[id] => 14435343
[patent_doc_number] => 20190175543
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-06-13
[patent_title] => Formulations Containing Amorphous Dapagliflozin
[patent_app_type] => utility
[patent_app_number] => 16/256490
[patent_app_country] => US
[patent_app_date] => 2019-01-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13450
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16256490
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/256490 | Formulations Containing Amorphous Dapagliflozin | Jan 23, 2019 | Abandoned |
Array
(
[id] => 14338565
[patent_doc_number] => 20190151255
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-05-23
[patent_title] => TOPICAL PHARMACEUTICAL COMPOSITIONS
[patent_app_type] => utility
[patent_app_number] => 16/255121
[patent_app_country] => US
[patent_app_date] => 2019-01-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 27942
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -1
[patent_words_short_claim] => 215
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16255121
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/255121 | Topical pharmaceutical compositions | Jan 22, 2019 | Issued |